Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.

Gingerich MA, Smith JD, Michmerhuizen NL, Ludwig M, Devenport S, Matovina C, Brenner C, Chinn SB.

Head Neck. 2018 May;40(5):943-954. doi: 10.1002/hed.25057. Epub 2018 Feb 10.

PMID:
29427520
2.

Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.

Hoesli R, Birkeland AC, Rosko AJ, Issa M, Chow KL, Michmerhuizen NL, Mann JE, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, McHugh JB, Brenner JC, Spector ME.

Oral Oncol. 2018 Feb;77:83-89. doi: 10.1016/j.oraloncology.2017.12.003. Epub 2017 Dec 23.

PMID:
29362129
3.

Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.

Birkeland AC, Foltin SK, Michmerhuizen NL, Hoesli RC, Rosko AJ, Byrd S, Yanik M, Nor JE, Bradford CR, Prince ME, Carey TE, McHugh JB, Spector ME, Brenner JC.

Oral Oncol. 2017 May;68:5-8. doi: 10.1016/j.oraloncology.2017.02.025. Epub 2017 Mar 10.

4.

Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC.

Mann JE, Hoesli R, Michmerhuizen NL, Devenport SN, Ludwig ML, Vandenberg TR, Matovina C, Jawad N, Mierzwa M, Shuman AG, Spector ME, Brenner JC.

J Cancer. 2017 Feb 9;8(3):332-344. doi: 10.7150/jca.17547. eCollection 2017. Review.

5.

Genomic sequencing and precision medicine in head and neck cancers.

Hoesli RC, Ludwig ML, Michmerhuizen NL, Rosko AJ, Spector ME, Brenner JC, Birkeland AC.

Eur J Surg Oncol. 2017 May;43(5):884-892. doi: 10.1016/j.ejso.2016.12.002. Epub 2016 Dec 15. Review.

6.

Differential compensation mechanisms define resistance to PI3K inhibitors in PIK3CA amplified HNSCC.

Michmerhuizen NL, Leonard E, Kulkarni A, Brenner JC.

Otorhinolaryngol Head Neck Surg. 2016;1(2):44-50. Epub 2016 Jun 7.

7.

Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine.

Michmerhuizen NL, Birkeland AC, Bradford CR, Brenner JC.

Genes Cancer. 2016 May;7(5-6):182-200. doi: 10.18632/genesandcancer.110.

8.

Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.

Birkeland AC, Yanik M, Tillman BN, Scott MV, Foltin SK, Mann JE, Michmerhuizen NL, Ludwig ML, Sandelski MM, Komarck CM, Carey TE, Prince ME, Bradford CR, McHugh JB, Spector ME, Brenner JC.

JAMA Otolaryngol Head Neck Surg. 2016 Jun 1;142(6):559-67. doi: 10.1001/jamaoto.2016.0335.

9.

Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding protein.

van Dongen MA, Rattan R, Silpe J, Dougherty C, Michmerhuizen NL, Van Winkle M, Huang B, Choi SK, Sinniah K, Orr BG, Banaszak Holl MM.

Mol Pharm. 2014 Nov 3;11(11):4049-58. doi: 10.1021/mp500608s. Epub 2014 Oct 1.

10.

An isothermal titration and differential scanning calorimetry study of the G-quadruplex DNA-insulin interaction.

Timmer CM, Michmerhuizen NL, Witte AB, Van Winkle M, Zhou D, Sinniah K.

J Phys Chem B. 2014 Feb 20;118(7):1784-90. doi: 10.1021/jp411293r. Epub 2014 Feb 4.

PMID:
24459986

Supplemental Content

Loading ...
Support Center